Additionally, metformin may inhibit cellular proliferation and promote partial cell cycle arrest in cancer cell lines through interactions with the adenosine monophosphate‐activated protein kinase (AMPK) metabolism by inhibition of the AMPK/liver kinase B‐1 dependent growth pathway or reducing systemic circulating insulin levels.42, 43. Here, INS is linked to cancer.